Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
F
Fadel, Michael
The Royal Marsden Hospital NHS Foundation Trust
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Michael Fadel
Fahy, Bridget
University of New Mexico, Division of Surgical Oncology
Colorectal Parallel Session
Location:Ballroom C
Bridget Fahy
Fakih, Marwan
City of Hope National Medical Center
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Marwan Fakih
Falla Zuniga, Luis Felipe
Mercy Medical Center
24: Sufficient Regional Lymph Node Examination for Staging High-Grade Appendix Cancer
Location:Ballroom C
Luis Felipe Falla Zuniga
Fan, Teresa
University of Kentucky, Department of Toxicology and Cancer Biology
P40: Exosomal isolation of immune checkpoints from pancreatic ductal adenocarcinoma patient-derived organoids
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Teresa Fan
Farah, Emile
UT Southwestern Medical Center
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Emile Farah
P18: Perioperative Outcomes of Robotic and Laparoscopic Surgery for Colorectal Cancer: A Propensity Score Matched Analysis
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Emile Farah
Faries, Mark
The Angeles Clinic and Research Institute/ Cedars-Sinai Medical Center
61: Smoking imparts shorter disease specific survival in patients with primary cutaneous melanoma
Location:Veterans Memorial Auditorium
Mark Faries
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
Mark Faries
Farma, Jeffrey
Fox Chase Cancer Center
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Jeffrey Farma
Mucosal Melanoma - Adjuvant Therapy, Margins
Location:SSO HUB: Melanoma & Sarcoma Zone
Jeffrey Farma
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Jeffrey Farma
P74: Perceptions of Readiness for Practice after Complex General Surgical Oncology Fellowship: A Survey Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Jeffrey Farma
Fasano, Genevieve
Weill Cornell Medicine
P8: Breast Cancer Among Asian Women in New York City: Disparities in Presentation and the Need for Disaggregated Data
Location:SSO HUB: Breast & Endocrine Zone
Genevieve Fasano
Fayanju, Oluwadamilola
The University of Pennsylvania / Penn Medicine
P67: Neighborhood Deprivation and Breast Cancer Outcomes in Philadelphia
Location:SSO HUB: Rare/Metastatic Cancers Zone
Oluwadamilola Fayanju
Strategies to Increase Enrollment of Diverse Populations in Clinical Trials
Location:SSO HUB: Rare/Metastatic Cancers Zone
Oluwadamilola Fayanju
Fedro, Joseph
Division of Colon and Rectal Surgery, Department of Surgery, The Ohio State Wexner Medical Center
P13: Multiomic Profile of Colorectal Cancer Cell Line Radiosensitivity
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Joseph Fedro
Fei, Teng
Memorial Sloan Kettering Cancer Center
93: Effectiveness of Sentinel Lymph Node Mapping in Gastric Cancer
Location:Ballroom A
Teng Fei
P82: Short- and Long- Term Outcomes of Minimally Invasive vs Open Gastrectomy after Neoadjuvant Chemotherapy for Gastric cancer.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Teng Fei
Fei-Zhang, David
Northwestern University - Feinberg School of Medicine
P68: The Impact of Digital Inequities on Gastrointestinal Cancer Disparities in the US
Location:SSO HUB: Rare/Metastatic Cancers Zone
David Fei-Zhang
Ferguson, Benjamin
Memorial Sloan Kettering Cancer Center
93: Effectiveness of Sentinel Lymph Node Mapping in Gastric Cancer
Location:Ballroom A
Benjamin Ferguson
Ferrandon, Sylvain
Division of Colon and Rectal Surgery, Department of Surgery, The Ohio State Wexner Medical Center
P13: Multiomic Profile of Colorectal Cancer Cell Line Radiosensitivity
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Sylvain Ferrandon
Ferrone, Cristina
Cedars-Siani
CON: Neoadjuvant Therapy Should be Routinely Given for High-risk Intrahepatic Cholangiocarcinoma
Location:Ballroom A
Cristina Ferrone
Rebuttal and Discussion
Location:Ballroom A
Cristina Ferrone
Fields, Ryan
Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine
22: The Long non-coding RNA RAMS11 Promotes Chemotherapy Resistance in-vivo in Metastatic Colorectal Cancer.
Location:Ballroom C
Ryan Fields
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Ryan Fields
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Ryan Fields
Fiore, Marco
Fondazione IRCCS Istituto Nazionale dei Tumori
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Marco Fiore
P64: Surgical management of the duodenum during multivisceral resection for retroperitoneal sarcoma (RPS)
Location:SSO HUB: Melanoma & Sarcoma Zone
Marco Fiore
Fiorentini, Guido
Mayo Clinic
51: Response to neoadjuvant chemotherapy in invasive intraductal papillary mucinous cystic neoplasm compared to de novo pancreatic ductal adenocarcinoma
Location:Ballroom A
Guido Fiorentini
Fischer, Trevan
Saint John's Cancer Institute, Donald L Morton CGSO Fellowship
61: Smoking imparts shorter disease specific survival in patients with primary cutaneous melanoma
Location:Veterans Memorial Auditorium
Trevan Fischer
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
Trevan Fischer
Fisher, Charles
Department of Anesthesia
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma
Location:Veterans Memorial Auditorium
Charles Fisher
Fisher, Christine
University of Colorado School of Medicine, Department of Radiology
P9: Comparing Patient Reported Outcomes for Same-day Discharge and Inpatient Admission After Mastectomy
Location:SSO HUB: Breast & Endocrine Zone
Christine Fisher
Fisher, James
The Ohio State University College of Public Health
82: Socioeconomic Disparities in the Treatment and Survival of Extremity Soft Tissue Sarcoma
Location:Ballroom B
James Fisher
Fisher, Sarah
The University of Texas MD Anderson Cancer Center Hospital
Management of Differentiated Thyroid Cancer in the Era of Targeted Therapy
Location:SSO HUB Theater
Sarah Fisher
Fisher, Terry
Vaccinex, Inc
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Terry Fisher
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Terry Fisher
Fisher, William
Baylor College of Medicine
45: Differential Immune Signatures are Associated with Racial Disparities in Pancreatic Cancer
Location:Ballroom A
William Fisher
Fitzal, Florian
Department of Surgery and Breast Health Center, Medical University of Vienna, Vienna, Austria; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Florian Fitzal
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Florian Fitzal
FitzSullivan, Elizabeth
The University of Texas MD Anderson Cancer Center
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Location:Veterans Memorial Auditorium
Elizabeth FitzSullivan
Fleming, Andrew
University of Tennessee Health Science Center
P27: Follicular Thyroid Carcinoma with Nodal Metastases: A National Study
Location:SSO HUB: Breast & Endocrine Zone
Andrew Fleming
Fleming, Fergal
University of Rochester Medical Center
85: Impact of Incident Hospital-Acquired Geriatric Syndromes on Short-term Outcomes following Gastrointestinal Cancer Resection
Location:Ballroom B
Fergal Fleming
Colorectal Poster Presentations 2
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Fergal Fleming
Fleming, Jason
Moffitt Cancer Center
Post-discharge VTE PProphylaxis after HPB Surgery: PRO vs CON
Location:SSO HUB: Rare/Metastatic Cancers Zone
Jason Fleming
PRO
Location:SSO HUB: Rare/Metastatic Cancers Zone
Jason Fleming
Fleming, Nicole
MD Anderson Cancer Center
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Nicole Fleming
Fletcher, Ashley
Duke University
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Ashley Fletcher
Flexman, Alana
UBC
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Alana Flexman
Flores Moreno, Sonia Maria
Hospital Regional Materno Infantil, Monterrey, Mexico
GPPO2: PEDICULATED LATERAL THORACIC FLAP AS VOLUME REPLACEMENT IN BREAST CONSERVATIVE SURGERY
Location:Ballroom C
Sonia Maria Flores Moreno
Floyd, Tamara
Allegheny Health Network
P55: Defining Values and Quality of Life of Cancer Survivors following Cytoreductive Surgery and HIPEC: An International Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Tamara Floyd
Fluke, Laura
Providence Saint John's Cancer Institute
61: Smoking imparts shorter disease specific survival in patients with primary cutaneous melanoma
Location:Veterans Memorial Auditorium
Laura Fluke
81: Racial and socioeconomic disparities in colorectal cancer screening during the COVID-19 pandemic
Location:Ballroom B
Laura Fluke
Fogliati, Alessandro
Mayo Clinic
51: Response to neoadjuvant chemotherapy in invasive intraductal papillary mucinous cystic neoplasm compared to de novo pancreatic ductal adenocarcinoma
Location:Ballroom A
Alessandro Fogliati
Fong, Yuman
City of Hope Medical Center
CON
Location:SSO HUB: Rare/Metastatic Cancers Zone
Yuman Fong
P35: Slow Adoption of Observation for Small Pancreatic Neuroendocrine Tumors
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Yuman Fong
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Yuman Fong
Fonseca, Annabelle
University of South Alabama
Should HPB Cancer Surgery be Regionalized?
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Annabelle Fonseca
Fontaine, Jacques
Moffitt Cancer Center
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer
Location:Ballroom A
Jacques Fontaine
Ford, Sam
University Hospital Birmingham NHS Foundation Trust
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Sam Ford
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Sam Ford
Forsythe, Steven
Wake Forest School of Medicine
66: Utilizing Organoids to Study Perfusate Selection in Appendiceal Cancer Patients Undergoing Repeat HIPEC
Location:Ballroom B
Steven Forsythe
68: Assessing the Mucolytic and Cytotoxic Activity of Bromelain in Appendiceal Cancer Organoids
Location:Ballroom B
Steven Forsythe
Foshag, Leland
St John's Cancer Institute
61: Smoking imparts shorter disease specific survival in patients with primary cutaneous melanoma
Location:Veterans Memorial Auditorium
Leland Foshag
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
Leland Foshag
Foster, Deshka
Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Deshka Foster
Foster, Jason
University of Nebraska/Fred and Pamela Buffet Cancer Center
PRO: HIPEC Should be Offered
Location:Ballroom B
Jason Foster
Rebuttal and Q&A
Location:Ballroom B
Jason Foster
Foster, Trenton
Endocrine and Metabolic Surgery, Department of Surgery, Mayo Clinic
P28: Hurthle cell carcinoma - Is a hemithyroidectomy enough?
Location:SSO HUB: Breast & Endocrine Zone
Trenton Foster
Frakes, Jessica
Moffitt Cancer Center
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer
Location:Ballroom A
Jessica Frakes
Francescatti, Amanda
American College of Surgeons
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Amanda Francescatti
P75: “Next Gen” Operative Notes – synoptic operative reporting for cancer surgery
Location:SSO HUB: Rare/Metastatic Cancers Zone
Amanda Francescatti
Frank, Elizabeth
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Elizabeth Frank
Frankel, Paul
City of Hope National Medical Center
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Paul Frankel
Frankel, Timothy
University of Michigan
41: Defining the immune microenvironment surrounding pancreatic cancer using single cell RNA sequencing
Location:Ballroom B
Timothy Frankel
Franses, Joseph
Massachusetts General Hospital Cancer Center
P15: Relationship of Repeat RNA Expression in Cancer Metastasis
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Joseph Franses
Freedman, Rachel
Dana-Farber Cancer Institute
2: Racial disparities in locoregional recurrence in patients with stage I-III, hormone receptor positive breast cancer enrolled in the NSABP B-42 trial
Location:Veterans Memorial Auditorium
Rachel Freedman
Frias, Chris
UCLA Health
79: Dysregulation of Mitochondrial Dynamics via Dynamin-Related Protein 1 Implicated in Dedifferentiated Liposarcoma
Location:Ballroom A
Chris Frias
Friedman, Adi
Tel-Aviv Sourasky Medical Center
90: Obesity and Gastric Cancer Aggressiveness – a New Link
Location:Veterans Memorial Auditorium
Adi Friedman
Fukunaga-Kalabis, Mizuho
Merck & Co., Inc., Rahway, NJ, USA
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Mizuho Fukunaga-Kalabis
Back to Top
